April 19 (Thu) – 20 (Fri), 2018
Crystal Ballroom (4F), Lotte City Hotel Jeju, Jeju Island, Korea


  • Program
  • Invited Speakers

Invited Speakers

Kazuo Tajima

Misugi Clinic, Japan
"Contribution of APOCP: General Perspective on Asian Cancer Epidemiology from Now On"

Malcolm Antony Moore

APJCP Editorial Office, APE Press, Thailand
"History of APOCP: History of the APOCP/APJCP"

Jeff Dunn

University of Southern Queensland, Australia
"Volunteerism: Mobilising Communities for Cancer Control"

Jin Soo Lee

National Cancer Center, Korea
"National Cancer Control Program in Korea"

Youlin Qiao

Chinese Academy of Medical Sciences, China
"Precise Prevention of Cervical Cancer and HPV Vaccination in China"

Young-Joon Surh

Seoul National University, Korea
"The Role of the Transcription Factor Nrf2 in Cancer Prevention"

Alireza Mosavi Jarrahi

Shahid Beheshti University, Iran
"Epidemiology of Childhood Cancer in Iran and West Asia"

Anton Barchuk

Petrov National Research Center of Oncology, Russia
"Implementation of Evidence-based Cancer Control Activities in Russia"

Cheng-Har Yip

Ramsay Sime Darby Health Care, Malaysia
"Financial Impact of Cancer in Low and Middle Income Countries"

David Roder

University of South Australia, Australia
"Extending Cancer Surveillance in Australia"

Elisabete Weiderpass

Institute of Population Based Cancer Epidemiology, Norway
"Biobanks and Registries for Epidemiological Research on Cancer in the Nordic Countries"

Harri Vainio

Kuwait University, Kuwait
"Prevention Paradox – Why Prevention is Celebrated in Principle But Not Effective in Practice?"

Hung Yi Chiou

Taipei Medical University, Taiwan
"Breast Cancer Survival after Cancer Screening Intervention in Taiwan"

Le Tran Ngoan

Hanoi Medical University, Vietnam
"Current Observational Achievements of Diet and Cancer: a Case Study on Meat Mutagens and Colorectal Adenoma and Cancer"

Nobuyuki Hamajima

Nagoya University, Japan
"Available Data on Cancer Frequency in Lao PDR"

Suzanne Chambers

Griffith University, Australia
"Quality of Life after Treatment for Prostate Cancer"